Ype de Jong
Co-Investigator (Project 3) and Core Director · Indiana University School of Medicine
Credentials: · · ·
History
- Present
Cornell Univ Joan and Sanford I Weill Med Coll · New York Presbyterian Hospital
- 2006–2009
Gastroenterology
- 2003–2006
Internal Medicine
- 1999–2003
University of Amsterdam Faculty of Medicine Netherlands
Research
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
Nature · 2009 · 730 citations
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
Cell · 2018 · 670 citations
Immune Responses to Viral Gene Therapy Vectors
Review · Molecular Therapy · 2020 · 607 citations
- AB
10 papers
6 papers · 4 as a resident
5 papers
4 papers
- LS
4 papers
- SB
4 papers
4 papers
3 papers
Grants
- 2026–2031
Elucidating the Host and Viral Determinants of Treatment Response in Chronic Hepatitis B
National Institute of Allergy and Infectious Diseases · R01
PI · $862.7K · Rockefeller University
- 2016–2029
Enhancing Immune Regulation in Gene Therapy for Hemophilia
National Heart, Lung, and Blood Institute · R01
PI · $7.2M · Indiana University Indianapolis
- 2022–2027
Toward Safer Gene Therapy for Hemophilia A
National Heart, Lung, and Blood Institute · P01
Project lead · $1.9M · Indiana University Indianapolis
- 2019–2025
Modeling Alcohol Toxicity in Human Hepatocytes
National Institute on Alcohol Abuse and Alcoholism · R01
Contact PI · $1.9M · Weill Medical Coll of Cornell Univ